Comparison of Quality of Life in Patients Undergoing More Intensive Versus

Status Completed

Clinical Trial Summary

This study will examine the quality of life of patients undergoing bone marrow transplantation to treat a blood disease. It will look at how this therapy affects many areas of life, including for example, personal relationships, work, and general emotional state. The information gained may lead to improved ways of dealing with problems that may arise before or during treatment.

Patients receiving bone marrow stem cells donated by a family member may participate in this study. They will be interviewed before treatment begins and will complete questionnaires at the following intervals:

1. day of admission to the hospital

2. day of the transplant

3. 30 days after the transplant

4. 100 days after the transplant

5. 1 year after therapy

6. 2 years after therapy

All questionnaires to be completed after discharge from the hospital will be scheduled during a regular follow-up visit. Each questionnaire takes about 15 to 20 minutes to complete. The information provided is confidential and will not be shared.

Clinical Trial Description

Clinical research in blood stem cell and bone marrow transplantation documents improvements in disease free intervals, disease free survival, and the severity of treatment related toxicities. However, it is important for patients and families to know the quality of life (QOL) they can expect following an allogeneic transplant. In this longitudinal study we will compare the QOL of patients undergoing a non-myeloablative allogeneic peripheral blood stem cell transplant (A-PBSCT) prospectively with that of a myeloablative A-PBSCT. Subjects (n=106) over the age of 18 will be enrolled. Measures of quality of life (Medical Outcomes Study Short Form-MOS SF-36 and Functional Assessment of Cancer Therapy-General and Bone Marrow Transplant - FACT-G and FACT-G/BMT) and symptom distress (Symptom Distress Scale - SDS) will be administered prior to transplant (baseline) and at set interval post transplant. Data will be analyzed using repeated measures analysis of variance and regression analysis. ;

Study Design

N/A

Related Conditions & MeSH terms

Bone Marrow Transplantation

Clinical Trial Details

NCT number	NCT00004994
Study type	Observational
Source	National Institutes of Health Clinical Center (CC)
Contact
Status	Completed
Phase	N/A
Start date	October 1999
Completion date	October 2004

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06148610` - Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
Completed	`NCT02212236` - Psychological Intervention for Distress During HSCT	Phase 2
Completed	`NCT00023530` - Blood and Marrow Transplant Clinical Research Network	N/A
Completed	`NCT01466335` - An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers	Phase 1
Withdrawn	`NCT02682953` - Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers	Phase 2
Completed	`NCT00775632` - Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants	Phase 2
Completed	`NCT00048256` - Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates	N/A
Completed	`NCT04039100` - Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease	N/A
Completed	`NCT04535570` - Evolution of the Energy Expenditure During Hematopoietic Stem Cell Transplantation
Recruiting	`NCT06118853` - Impact of Yoga and Gentle Massage Practices on Symptom Management in Patients Undergoing HSCT	N/A
Active, not recruiting	`NCT01016093` - Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients	Phase 2/Phase 3
Completed	`NCT01015183` - Prevention Chemotherapy Induced Mucositis by Zinc Sulfate	Phase 2/Phase 3
Completed	`NCT00843180` - Massage for Pediatric Oncology	N/A
Completed	`NCT00000591` - T-Cell Depletion in Unrelated Donor Marrow Transplantation	Phase 3
Completed	`NCT04474730` - Physical Activity Monitoring Among BMT Patients	N/A
Completed	`NCT02733744` - Fecal Microbiota Transplantation After HSCT	Early Phase 1
Active, not recruiting	`NCT02319226` - Toward Immune Biomarkers for Tolerance and GvHD in Humans
Recruiting	`NCT00673348` - Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations	N/A
Completed	`NCT00005556` - Retention of Bone Marrow Donors in a National Registry	N/A
Completed	`NCT05391347` - Effects of Orange Oil Aromatherapy on the Pain and Anxiety	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms